In Episode 3 of the "Brain Cancer Science Talk" series on #MissionGBM, we chat with John de Groot, MD (Division Chief of Neuro-Oncology, UCSF) about immunotherapies, the need for combination protocols, Focused Ultrasound, and necessary improvements to clinical trial design and Regulatory framework to advance the development of treatment options for #braincancer patients. #FUS #ImmunoOncology #GBM #Onward #Nof1onBehalfofAll
Scott L. Rakestraw’s Post
More Relevant Posts
-
Good to see AstraZeneca increasing its activity in #NeuroOncology. Several Pharmas are active in the space, which can only enhance the quality of science and pace of drug development. Onward!
Senior Scientist, Neuro Oncology Discovery Waltham, MA Bakhos Tannous is seeking a highly motivated Senior Scientist with a background in T cell engagers and immunology to join our dynamic team in Waltham, MA. This is an exciting opportunity to contribute to our mission of eliminating cancer as a cause of death. As a Senior Scientist, you will be a key player in supporting Neuro Oncology projects through the drug discovery process, using your expertise in T cell engager and immunology to establish assay systems and deliver datasets that will have direct impact on pipeline programs. Are you ready to make a significant impact in the field of Neuro Oncology? Apply now: https://bit.ly/3VrZhcL #astrazeneca #oncology #tcell #drugdiscovery
-
-
True science- and evidence-based innovation in Neuro-Oncology has been infrequent over the past 50 years. So when an exceptional physician/scientist such as #DavidDTran, MD, PhD of the Brain Tumor Center at the University of Southern California follows the #Data to create a compelling treatment option for #GBM and #Glioma patients, it gets our attention. Please watch the linked video at #MissionGBM to learn how strong science and global teamwork have translated to hope for patients.
David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)
missiongbm.com
-
Congrats to #HowardYChang, MD, PhD of Stanford University on being named the 2024 recipient of the Lurie Prize in Biomedical Sciences. Dr. Chang’s work to elucidate the role and importance of long non-coding RNA represents a fundamental breakthrough in understanding the biology of many diseases.
-
If you want to see what it looks like when two dedicated #BrainCancer warriors develop a relationship over 2+ years, and relentlessly focus on translating basic oncology research into treatment options for patients, then we encourage you to watch this video chat on #MissionGBM. Many thanks to #PaulMischel for his molecular oncology leadership, and for ALWAYS saying "Yes" to rigorous science and collaboration. #GBM #Onward #Nof1onBehalfofAll #Stanford #InnovativeMedicinesAccelerator
Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)
missiongbm.com
-
For "Brain Cancer Science Talk" Episode 4 on #MissionGBM, we chat with Samuel Blackman of #DayOneBiopharmaceuticals about making a difference in the lives of pediatric oncology patients. It is a rare and treasured experience when two longtime #Biopharma warriors get to spend 35 minutes talking about the reason why we can't wait to get out of bed every morning. The patients are waiting...what other reason does one need? #Onward #Nof1onBehalfofAll #BrainCancer #Science #Data
Samuel Blackman, MD, PhD – Brain Cancer Science Talk (Episode 4)
missiongbm.com
-
In Episode 2 of the "Brain Cancer Science Talk" series on #MissionGBM, we chat with Graeme Woodworth, MD (Chair of Neurosurgery, Director of the Brain Tumor Program, University of Maryland) about innovation in neurosurgical techniques and MR-guided Focused Ultrasound methods to transiently open the BBB for the purposes of diagnosing and treating brain cancers. Check it out, and stay tuned for more one-on-one Series discussions with the world's top brain cancer physician/scientists. Two scientists walk into a (Zoom) bar...and put their brains together. #braincancer #GBM #FUS #LITT #Connectomics
Graeme Woodworth, MD – Brain Cancer Science Talk (Episode 2)
missiongbm.com
-
Check out Episode 1 of the "Brain Cancer Science Talk" series on #MissionGBM. Michael L. Dougan, MD, PhD (MGH, Harvard Medical School) talks with us about understanding and managing immune-related AEs (irAEs) in immuno-oncology treatment protocols. Bottom Line: Careful design and monitoring of individual I-O treatment regimens can manage irAEs for most patients, allowing them to safely achieve therapeutic benefit. Stay tuned for more intriguing Series interviews with the best brain cancer physicians and scientists. After all, two scientists walk into a bar...and put their brains together. #braincancer #GBM #immunooncology
Michael L. Dougan, MD, PhD – Brain Cancer Science Talk (Episode 1)
missiongbm.com
-
Sam Blackman’s highly personal video post should be required as part of every medical school, graduate program and business school in the world…as well as all (performative) political offices. Want to know what it’s like to really make a difference in the world? Just watch this video. Thanks very much, Sam, for posting this gem.
As many of you know, I do like to write things. And on the occasion of our recent approval, I had some thoughts. It took a while for me to get them out as last week was a whirlwind of emotion and meetings and travel and celebration. But I finally did. Instead of putting them in print, however, I decided to just say them (warning: this may exceed the MTD of Sam for most people). Finally, for everyone who sent a lovely note, thank you. I read every single one.
